Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Review critical factors to watch before investing in Dividend Aristocrats Etf, such as dividend stability, sector concentration, and expense ratios.
24,514 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
The NRC granted TerraPower a construction permit for a sodium-cooled reactor in Wyoming, marking a watershed for adva...
A casual taste-test clip by McDonald’s CEO ignited a social-media firestorm. The incident quickly evolved into a broa...
Tech-led selling pushed the Nasdaq Composite lower as investors weigh higher yields and fresh data. The broader marke...
Oil prices surged as tensions with Iran intensified, signaling higher pump costs for consumers. Analysts warn househo...
Childcare costs are climbing for providers and families alike, pushing tuition higher and forcing tough choices as af...
As crypto markets stabilize, investors ask if coinbase stock finally buy? signals a bottom. The company shows cash st...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
A key Fed decision on March 18 could set the tone for inflation and, in turn, the Social Security COLA for 2027. Reti...
From public housing in Brooklyn to Harvard at 16 and a 12-year Goldman Sachs tenure, the former Goldman Sachs leader ...
The year 2025 saw disaster costs ease, yet losses exceeded $100 billion four times in five years. Insurers remain cau...
Analysts raise the oracle price target $240 after Oracle reports resilient AI cloud demand and stronger-than-expected...